Host: John J. Russell, MD Guest: Steven W. Pipe, MD Hemophilia A and hemophilia B are congenital X-linked bleeding disorders caused by deficiency of coagulation factor VIII (FVIII) and IX (FIX). While the life expectancy of patients with hemophilia

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Andrew M. Kaunitz, MD, FACOG The estrogen component of combined oral contraceptives in part helps to suppress FSH and folliculogenesis, stabilizes the endometrium, minimizes unscheduled bleeding, and su

Host: Leslie Citrome, MD, MPH Guest: Christoph U. Correll, MD Dr. Leslie Citrome and Dr. Christoph Correll discuss the clinical trial data of current and emerging antipsychotic therapy for bipolar I disorder and schizophrenia. They provide insight

Host: Mimi Secor, DNP, FNP-BC, FAANP Guest: Karen Bloch, MD, MPH, FIDSA, FACP Guest: Jarrod W. Kile, RPh, BCPS Hear from a multidisciplinary, interprofessional panel of experts on COVID-19 infusion therapies with virus-neutralizing monoclonal ant

Guest: Richard Channick, MD Guest: Vallerie Mclaughlin, MD Pulmonary Arterial Hypertension is a progressive disease and is associated with poor clinical outcomes. This first live webinar provides an in-depth discussion of the new thresholds for the

Host: Jennifer Caudle, DO Guest: Andrew D. Badley, MD, FRCP(C), FACP, FIDSA Guest: Chad Worz, PharmD, BCGP, FASCP The United States is one of the hardest hit countries with SARS-CoV-2 with many more deaths expected in early 2021. Outpatient infus

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Anita L. Nelson, MD Although oral contraceptives were first introduced approximately 60 years ago, we continue our efforts today to identify new estrogens and progestins that improve cycle control while

Guest: Janet B. McGill, MD, MA, FACE, FACP Host: John J. Russell, MD Type 2 diabetes mellitus (T2DM) represents the main cause of chronic kidney disease and end-stage renal disease, accounting for almost 50 percent of all patients starting renal re

Host: Gregory Lewis, MD Guest: Michael Böhm, MD, FESC Guest: Josep Comin-Colet, MD, PhD Do you know that as many as 70% of patients hospitalized with heart failure are iron deficient? This condition is associated with reduced functional capacity

Host: Jennifer W. Carlisle, MD Guest: Suresh S. Ramalingam, MD Targeted therapy has revolutionized the treatment of advanced non–small-cell lung cancer (NSCLC) across a broad range of molecular aberrations. The epidermal growth factor receptor (EGF